Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design
Fujiki, Shinya, Iijima, Kenichi, Okabe, Masaaki, Niwano, Shinichi, Tsujita, Kenichi, Naito, Shigeto, Ando, Kenji, Kusano, Kengo, Kato, Ritsushi, Nitta, Junichi, Miura, Tetsuji, Mitsuhashi, Takeshi, KaVolume:
11
Journal:
Diabetes Therapy
DOI:
10.1007/s13300-020-00924-9
Date:
November, 2020
File:
PDF, 411 KB
2020